Design

GENEVA – The global health community is celebrating a landmark achievement today as the World Health Organization (WHO) announced the formal Prequalification of ‘Zolexifan’, the first-ever single-dose oral treatment for visceral leishmaniasis (VL), also known as kala-azar. This devastating neglected tropical disease (NTD) affects hundreds of thousands annually, and until…